Home/Healthcare/Biotechnology/North America Nuclear Medicine Market

North America Nuclear Medicine Market - Strategic Insights and Forecasts (2026-2031)

Market Size, Share, Growth and Trends Analysis By Applications (SPECT Market, PET Market), By Procedures (Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genito-urinary, Pulmonary), By End-User Industry (Hospitals, Diagnostic Centers, Research Institutes), and Geography

Market Size in 2026
USD 8.28 billion
Market Size in 2031
USD 16.5 billion
CAGR
14.8%
Study Period
2021-2031
$3,250
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

North America Nuclear Medicine Market is projected to surge at a CAGR of 14.8%, reaching USD 16.5 billion in 2031 from USD 8.28 billion in 2026.

North America Nuclear Medicine Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $8.28B in 2026 to $16.50B by 2031 at a CAGR of 14.8%.
North America Nuclear Medicine Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $8.28B in 2026 to $16.50B by 2031 at a CAGR of 14.8%.

This research study examines the Nuclear medicine market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in addition to the recent developments, have been provided in this report.  The report also analyzes key players in the nuclear medicine market. The report provides comprehensive forecast up to the period 2022 for various key segments, with 2016 as base year.        

The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments. Moreover, the research study analyzes the overall regulatory framework of the North American nuclear medicine market, offering stakeholders a better understanding of the key factors affecting the overall market environment.

The first step towards determining the nuclear medicine market size involves identifying key players and the revenue contribution of the overall business or relevant segment aligned to the study in consideration through extensive secondary research. This also includes various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others. Both bottom-up and top down approaches are utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the nuclear medicine value chain, who are C-Level Executives, Directors, and Managers among others across key enterprises operating as manufacturers, suppliers, and distributors. The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the gathered data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Key industry players profiled as part of this section are BRACCO PHARMA, Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Fujifilm Holdings Corporation, GE Healthcare (Subsidiary of General Electric Company), Nordion, Inc., and Taiyo Nippon Sanso Corporation among few others.  

North America Nuclear Medicine Market Scope

Report Metric Details
Total Market Size in 2026 USD 8.28 billion
Total Market Size in 2031 USD 16.5 billion
Forecast Unit Billion
Growth Rate 14.8%
Study Period 2021 to 2031
Historical Data 2021 to 2024
Base Year 2025
Forecast Period 2026 – 2031
Segmentation Applications, Procedures, End-User Industry, Geography
Companies
  • Bracco
  • Cambridge Isotope Laboratories Inc.
  • Cardinal Health
  • Fujifilm Holdings Corporation
  • GE Healthcare

Market Segmentation

By Applications
  • SPECT Market
  • PET Market
By Procedures
  • Central Nervous System
  • Endocrine
  • Skeletal
  • Gastrointestinal
  • Genito-urinary
  • Pulmonary
By End-User Industry
  • Hospitals
  • Diagnostic centers
  • Research Institutes
By Geography
  • North America
  • US
  • Mexico
  • Canada
  • Others

Table of Contents

1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. North American Nuclear Medicine Market Forecast by Applications (US$ Billion)
5.1. Introduction
5.2. SPECT Market
5.3. PET Market
6. North American Nuclear Medicine Market Forecast by Procedures (US$ Billion)
6.1. Introduction
6.2. Central Nervous System
6.3. Endocrine
6.4. Skeletal
6.5. Gastrointestinal
6.6. Genito-urinary
6.7. Pulmonary
7. North American Nuclear Medicine Market Forecast by End-User Industry (US$ Billion)
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic centers
7.4. Research Institutes
8. North American Nuclear Medicine Market Forecast by Geography (US$ Billion)
8.1. Introduction
8.2. North America
8.2.1. US
8.2.2. Mexico
8.2.3. Canada
8.2.4. Others
9. Competitive Intelligence
9.1. Strategies of Key Players
9.2. Recent Investments and Deals
10. Company Profiles
10.1. Introduction
10.2. Bracco
10.2.1. Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Key Developments 
10.3. Cambridge Isotope Laboratories, Inc. 
10.3.1. Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Key Developments 
10.4. Cardinal Health 
10.4.1. Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Key Developments 
10.5. Fujifilm Holdings Corporation
10.5.1. Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Key Developments 
10.6. GE Healthcare (Subsidiary of General Electric Company) 
10.6.1. Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Key Developments 
10.7. Nordion, Inc. 
10.7.1. Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Key Developments 
10.8. Taiyo Nippon Sanso Corporation
10.8.1. Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Key Developments 
10.9. Lantheus Medical Imaging, Inc.
10.9.1. Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Key Developments 
10.10. Koninklijke Philips N.V
10.10.1. Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Key Developments 
10.11. Digirad Corporation
10.11.1. Overview
10.11.2. Financials
10.11.3. Products and Services
10.11.4. Key Developments 
List of Tables
List of Figures
Navigate

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061610987
PublishedMay 2026
Pages114
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

This report anticipates that the North America Nuclear Medicine Market will grow significantly over the forecast period, providing a comprehensive outlook up to the year 2022. It highlights major drivers, restraints, and opportunities to offer an exhaustive picture of the market's future trajectory. The analysis uses 2016 as its base year for projections.

The research study meticulously examines the North America Nuclear Medicine Market on the basis of various key segments. The report provides comprehensive forecasts for these specific segments, enabling stakeholders to understand the detailed market breakdown and performance across different areas within nuclear medicine.

Yes, the report presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical segments within North America. Furthermore, it analyzes the overall regulatory framework of the North American nuclear medicine market, offering stakeholders a better understanding of key factors affecting the market environment.

The report profiles several key industry players operating in the North America Nuclear Medicine Market. These include BRACCO PHARMA, Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Fujifilm Holdings Corporation, GE Healthcare (Subsidiary of General Electric Company), Nordion, Inc., and Taiyo Nippon Sanso Corporation, among others, providing insights into their market contributions.

This report provides an exhaustive picture of the North America Nuclear Medicine Market by detailing its major drivers, restraints, and opportunities. It also incorporates current market trends related to demand, supply, and sales, in addition to recent developments, to offer a complete understanding of the factors influencing the market's strategic direction.

The market size was determined by identifying key players and their revenue contributions through extensive secondary research, including industry associations and analyst reports. Both bottom-up and top-down approaches were utilized, with values correlated against primary inputs from C-Level Executives, Directors, and Managers across the value chain. Complete market engineering, using various data triangulation methods, was involved for market breakdown and forecasting.

Need data specifically for your business?Request Custom Research β†’
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon